Skip to main content

Healthcare News

 

Clinical courses

 

Clinical courses

  • According to business intelligence provider GBI (GlobalBusinessIntelligence) Research In 2013,  The US treatment market for rheumatoid arthritis (RA) was $6.4 billion and which get rising to $9.3 billion by 2020, representing a Compound Annual Growth Rate (CAGR) of 5.5%. Resaon behind this sudden growth  is US’ increasing prevalent population, which is reported  to hit 1.68 million by 2020. Consequently, marketcurrently makes up the  largest treatmentarea of the eight major pharmaceutical markets (the US, UK, Canada, France, Germany, Spain, Italy and Japan).

    (adsbygoogle = window.adsbygoogle || []).push({});
  • In India Dental treatments are 65 to 90 per cent cheaper than the developed world. The favourable cost-benefit ratio, quality and technological infrastructure in treatment attracting international patients from US, Europe, Middle East and South East Asian region to India.

  • The Ebola virus circulating in humans in West Africa is undergoing relatively few mutations, none of which suggest that it is becoming more severe or transmissible, according to a National Institutes of Health study in Science. The study compares virus sequencing data from samples taken from patients in Guinea (March 2014), Sierra Leone (June 2014) and Mali (November 2014).

  • (30th September, 2014; Business Wire India); Fortis Healthcare announced on last friday (26th sept) that Fortis Mulund, one of its major hospitals in Mumbai has been conferred the prestigious British Medical Journal (BMJ) Award for ‘The Medical Team of the Year 2014.’ The honour was bestowed on the hospital for its outstanding “Antibiotic Review Program – and Antibiotic Restriction Policy.”

  • (30th September, 2014; Business Wire India); Fortis Healthcare has been awarded the prestigious 2014 ‘Porter Prize, for Value Based Healthcare’. The prize was given in recognition of the company’s outstanding performance in the industry and for redefining the idea of patient care and fundamentally challenging the economic models within the industry.

  • (7th September, 2014); India and Australia are exploring cooperation possibilities in preventive healthcare, trauma care, geriatric medicine, diabetes research and mental illnesses. This found iteration in the dialogue held between the visiting Prime Minister of Australia, Mr Tony Abbott, and the Union Health Minister, Dr Harsh Vardhan, on 5th Sept, Friday.

  • (5th September, 2014; Business Wire India); “India & Japan have a big opportunity of working together in the area of healthcare. Japan has achieved its goal of longevity and healthy life for all its citizens. This knowledge and technology will benefit India as well as the rest of the world. Shri Narendra Modi, Hon’ble Prime Minister of India, has already extended an open invitation to COME MAKE IN INDIA.  India will give Japan a huge consuming population, excellent human resources and a low cost base for manufacturing and exporting healthcare solutions to the world”, said Rajesh Srivastava, Chairman, Rockland Hospitals. He was speaking on the topic: Creating Healthcare Access for Cancer Treatment: Sharing Japanese Solutions, during a two days seminar titled FICCI- Heal-2014 on 1 & 2 Sept in Delhi.

  • (13th August, 2014); Dr Harsh Vardhan, Minister for Health, has clarified that India does not have any confirmed or even suspected Ebola virus affected person. World Health Organization (WHO) had informed that one Indian passenger had travelled on the same flight in which Ebola virus patient (foreign national) was travelling from Monrovia to Lagos. This Indian passenger is back in India. He has been tracked and his health is being regularly monitored. The Health Minister said “We are happy to share that the said person is healthy, fit and fine.”


Subscribe to Healthcare News